A meal "eats" colorectal cancer In 2014, 65-year-old Mr. Yang and his wife traveled abroad. During the period, gastrointestinal discomfort and constipation symptoms occurred, but they didn't pay much attention at that time, thinki..
"About 5-6 years ago, we started to see some young patients with colorectal cancer, including some people in their 20s or 30s, which had never been seen before," Memorial Sloan Kettering Cancer Center (MSK ) Said Dr. Julio Garci..
In the past two years, with the deepening of research related to targeting and immunotherapy and genotyping, more and more drugs with good effects and fewer side effects have become new options for individualized treatment and c..
Medical personnel worldwide are developing new human antigen vaccines, including various types of cancer preventive and therapeutic. Click for details: The light of hope to end cancer-2019 global inventory of the latest cancer vac..
Before the start of the article, the first look at science.Understanding of MSI-H, MSS, MSI-LMSS (MicroSatellite stability), microsatellite stability, compared with MSI, there is no obvious MSI.MSI-H (MicroSatellite Instability-..
BRAF mutations occur in 15% of colorectal patients. There are no targeted drugs approved by the FDA so far, and the prognosis is poor. Among them, BRAF V600E is the most common mutation.Recently, the results of the Phase III BEACO..
The theme of the 2019 NCCN Annual Meeting is to expand biomarker testing to guide the precise treatment of cancer, as well as new changes to colorectal cancer (CRC) guidelines. The 5-year survival rate of colorectal cancer is onl..
Immunotherapy uses drugs to help the body's own immune system better recognize and destroy cancer cells. Immunotherapy can be used to treat patients with advanced colorectal cancer. Immune checkpoint inhibitor An important ..
Colorectal cancer is one of the most common malignant tumors. In China, the incidence of colorectal cancer is ranked 4th and 3rd among men and women, respectively. Entering a state of advanced disease, the treatment strategy for t..
Chronic inflammation is a predisposing factor for colorectal cancer, which is the third leading cause of cancer-related deaths in the United States. Dr. Anna Means and colleagues reported in the journal Cell and Molecular Gastro..